Inositol monophosphatase, the putative therapeutic target for lithium

Brain Research Reviews

Volumn 22, Issue 2, 1996, Pages 183-190

  Atack, John R ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Bipolar disorder; Depression; Inhibitor; Inositol; Inositol monophosphatase; Lithium; Mania; Phosphatidylinositol

Indexed keywords

INOSITOL PHOSPHATE; LITHIUM;

DEPRESSION; HUMAN; MANIA; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0030220460     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0173(96)00007-0     Document Type: Review

References (60)

1. [1] Allison, J.H. and Stewart, M.A., Reduced brain inositol in lithium-treated rats, Nature New, Biol., 233 (1971) 267-268.
2. [2] Allison, J.H., Blisner, M.E., Holland, W.H., Hipps, P.P. and Sherman, W.R., Increased brain myo-inositol 1-phosphate in lithium-treated rats, Biochem. Biophys, Res. Commun., 71 (1976) 664-670.
3. [3] Atack, J.R. and Fletcher, S.R., Inhibitors of inositol monophosphatase, Drugs Future, 19 (1994) 857-866.
4. [4] Atack, J.R., Rapoport, S.I. and Varley, C.L., Characterization of inositol monophosphatase in human cerebrospinal fluid, Brain Res., 613 (1993) 305-308.
5. + in the treatment of bipolar disorder, Trends Neurosci., 18 (1995) 343-349.
6. [6] Atack, J.R., Broughton, H.B. and Pollack, S.J., Structure and mechanism of inositol monophosphatase, FEBS Lett., 361 (1995) 1-7.
7. [7] Attwood, P.V., Ducep, J.-B. and Chanal, M.-C., Purification and properties of myo-inositol-1-phosphatase from bovine brain, Biochem. J., 253 (1988) 387-394.
8. [8] Balduini, W., Candura, S. and Costa, L.G., Regional development of carbachol-, glutamate-, norepinephrine-, and serotonin-stimulated phosphoinositide metabolism in rat brain, Dev. Brain. Res., 62 (1991) 115-120.
9. [9] Baraban, J.M., Toward a crystal-clear view of lithium's site of action, Proc. Natl. Acad. Sci. USA, 91 (1994) 5738-5739.
10. [10] Barkai, A.I., Dunner, D.L., Gross, H.A., Mayo, P. and Fieve, R.R., Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder, Biol. Psychiat., 13 (1978) 65-72.
11. [11] Berridge, M.J., Inositol trisphosphate and calcium signalling, Nature, 361 (1993) 315-325.
12. [12] Berridge, M.J., Downes, C.P. and Hanley, M.R., Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands, Biochem. J., 206 (1982) 587-595.
13. [13] Berridge, M.J., Downes, C.P. and Hanley, M.R., Neural and developmental actions of lithium: a unifying hypothesis, Cell, 59 (1989) 411-419.
14. [14] Bevilacqua, J.A., Downes, C.P. and Lowenstein, P.R., Visualization of agonist-stimulated inositol phospholipid turnover in individual neurons of the rat cerebral cortex and hippocampus, Neuroscience, 60 (1994) 945-958.
15. [15] Bunney Jr, W.E. and Garland-Bunney, B.L., Mechanisms of action of lithium in affective illness: basic and clinical implications. In H.Y. Meltzer (Ed.), Psychopharmacology: Third Generation of Progress, Raven Press, New York, 1987, pp. 553-565.
16. [16] Cooper, T.B., Pharmacokinetics of Lithium. In H.Y. Meltzer (Ed.), Psychopharmacology: Third Generation of Progress, Raven Press, New York, 1987, pp. 1365-1375.
17. [17] De Smedt, F., Verjans, B., Mailleux, P. and Erneux, C., Cloning and expression of human brain type I inositol 1,4,5-trisphosphate 5-phosphatase-High levels of mRNA in cerebellar Purkinje cells, FEBS Lett., 347 (1994) 67-72.
18. [18] Dixon, J.F., Lee, C.H., Los, G.V. and Hokin, L.E., Lithium enhances accumulation of [3H]inositol radioactivity and mass of second messenger inositol 1,4,5-trisphosphate in monkey cerebral cortex slices, J. Neurochem., 59 (1992) 2332-2335.
19. [19] Eisenberg Jr., F., D-Myoinositol 1-phosphate as product of cyclization of glucose 6-phosphate and substrate for a specfic phosphatase in rat testis, J. Biol. Chem., 242 (1967) 1375-1382.
20. [20] Fisher, S.K., Heacock, A.M. and Agranoff, B.W., Inositol lipids and signal transduction in the nervous system: an update, J. Neurochem., 58 (1992) 18-38.
21. [21] Gani, D., Downes, C.P., Batty, I. and Bramham, J., Lithium and myo-inositol homeostasis, Biochim. Biophys. Acta, 1177 (1993) 253-269.
22. [22] Gee, N.S., Ragan, C.I., Watling, K.J., Aspley, S., Jackson, R.G., Reid, G.G., Gani, D. and Shute, J.K., The purification and properties of myo-inositol monophosphatase from bovine brain, Biochem. J., 249 (1988) 883-889.
23. 13C NMR spectroscopy of myo-inositol in the human brain in vivo, Magn. Reson. Med., 25 (1992) 204-210.
24. [24] Hallcher, L.M. and Sherman, W.R., The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain, J. Biol. Chem., 255 (1980) 10896-10901.
25. [25] Heacock, A.M., Fisher, S.K. and Agranoff, B.W., Enhanced coupling of neonatal muscarinic receptors in rat brain to phosphomositide turnover, J. Neurochem., 48 (1987) 1904-1911.
26. [26] Heacock, A.M., Seguin, E.B. and Agranoff, B.W., Developmental and regional studies of the metabolism of inositol 1,4,5-trisphosphate in rat brain, J. Neurochem., 54 (1990) 1405-1411.
27. [27] Hokin, L.E., Lithium increases accumulation of second messenger inositol 1,4,5-trisphosphate in brain cortex slices in species ranging from mouse to monkey, Advan. Enzyme Regul., 33 (1993) 299-312.
28. [28] Honchar, M.P., Ackermann, K.E. and Sherman, W.R., Chronically administered lithium alters neither myo-inositol monophosphatase activity nor phosphoinositide levels in rat brain, J. Neurochem., 53 (1989) 590-594.
29. [29] Hwang, P.M., Bredt, D.S. and Snyder, S.H., Autoradiographic imaging of phosphoinositide turnover in the brain, Science, 249 (1990) 802-804.
30. [30] Jope, R.S., Song, L. and Kolasa, K., Inositol trisphosphate, cyclic AMP. and cyclic GMP in rat brain regions after lithium and seizures, Biol. Psychiatry, 31 (1992) 505-514.
31. [31] Jope, R.S. and Williams, M.B., Lithium and brain signal transduction systems, Biochem. Pharmacol., 47 (1994) 429-441.
32. 31P-MRS, J. Affective Disorders, 22 (1993) 185-190.
33. [33] Kofman, O. and Belmaker, R.H., Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression, Biol. Psychiatry, 34 (1993) 839-852.
34. + increases accumulation of inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate in cholinergically stimulated brain cortex slices in guinea pig, mouse and rat - the increases require inositol supplementation in mouse and rat but not in guinea pig, Biochem. J., 282 (1992) 377-385.
35. [35] Lenox, R.H. and Watson, D.G., Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness, Clin. Chem., 40 (1994) 309-314.
36. [36] Levine, J., Gonzalves, M., Barbur, I., Stir, S., Elizur, A., Kofman, O. and Belmaker, R.H., Inositol 6 gm daily may be effective in depression but not in schizophrenia, Human Psychopharmacol., 8 (1993) 49-53.
37. [37] Levine, J., Rapaport, A., Lev, L., Bersudsky, Y., Kofman, O., Belmaker, R.H., Shapiro J. and Again G., Inositol treatment raises CSF inositol levels, Brain Res., 627 (1993) 168-170.
38. [38] Mailleux, P., Takazawa, K., Erneux, C. and Vanderhaeghen, J.-J., Inositol 1,4,5-trisphosphate 3-kinase mRNA: high levels in the rat hippocampal CA1 pyramidal and dentate gyrus granule cells and in cerebellar Purkinje cells, J. Neurochem., 56 (1991) 345-347.
39. [39] Mailleux, P., Takazawa, K., Erneux, C. and Vanderhaeghen, J.-J., Distribution of the neurons containing inositol 1,4,5-trisphosphate 3-kinase and its messenger RNA in the developing rat brain, J. Comp. Neurol., 327 (1993) 618-629.
40. [40] Majerus, P.W., Inositol phosphate biochemistry, Annu. Rev. Biochem., 61 (1992) 225-250.
41. [41] Manji, H.K. and Lenox, R.H., Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C, Synapse, 16 (1994) 11-28.
42. [42] Mayat, E., Lebrun, F., Sassetti, I. and Recasens, M., Ontogenesis of quisqualate-associated phosphoinositide metabolism in various regions of the rat nervous system. Int. J. Dev. Neurosci., 12 (1994) 1-17.
43. [43] Michaelis, T., Helms, G., Merboldt, K.D., Hanicke, W., Bruhn, H. and Frahm, J., Identification of scyllo-inositol in proton NMR spectra of human brain in vivo, NMR Biomed., 6 (1993) 105-109.
44. [44] Michell, R.H., Inositol lipids in cellular signalling mechanisms, Trends Biochem. Sci., 17 (1992) 274-276.
45. [45] Molchan, S.E., Atack, J.R. and Sunderland, T., Decreased CSF inositol monophosphatase activity after lithium treatment, Psychiatry Res., 53 (1994) 103-105.
46. [46] Moscovich, D.G., Belmaker, R.H., Agam, G. and Livne, A., Inositol-1-phosphatase in red blood cells of manic depressive patients before and during treatment with lithium, Biol. Psychiatry, 27 (1990) 552-555.
47. [47] Naccarato, W.F., Ray, R.E. and Wells, W.W., Biosynthesis of myo-inositol in rat mammary gland. Isolation and properties of the enzymes, Arch. Biochem. Biophys., 164 (1974) 194-201.
48. [48] Palmer, E., Nangel-Taylor, K., Krause, J.D., Roxas, A. and Cotman, C.W., Changes in excitatory amino acid modulation of phospho-inositide metabolism during development, Dev. Brain Res., 51 (1990) 132-134.
49. [49] Parthasarathy, L., Vadnal, R.E., Ramesh, T.G., Shyamaladevi, C.S. and Parthasarathy, R., myo-Inositol monophosphatase from rat testes: purification and properties, Arch. Biochem. Biophys., 304 (1993) 94-101.
50. [50] Parthasarathy, L., Vadnal, R.E., Parthasarathy, R. and Shyamala Devi, C.S., Biochemical and molecular properties of lithium-sensitive myo-inositol monophosphatase, Life Sci., 54 (1994) 1127-1142.
51. [51] Plenge, P., Stensgaard, A., Jensen, H.V., Thomsen, C., Mellerup, E.T. and Henriksen, O., 24-Hour lithium concentration in human brain studied by Li-7 magnetic resonance spectroscopy, Biol. Psychiatry, 36 (1994) 511-516.
52. [52] Sherman, W.R., Inositol homeostasis, lithium and diabetes. In R.H. Michell, A.H. Drummond, C.P. Downes (Eds.), Inositol Lipids in Cell Signalling, Academic Press, London, 1989, pp. 39-79.
53. [53] Sherman, W.R., Gish, B.G., Honchar, M.P. and Munsell, L.Y., Effects of lithium on phosphoinositide metabolism in vivo, Federation Proc., 45 (1986) 2639-2646.
54. [54] Takimoto, K., Okada, M., Matsuda, Y. and Nakagawa, Y., Purification and properties of myo-inositol-1-phosphatase from rat brain, J. Biochem. (Tokyo), 98 (1985) 363-370.
55. [55] White, K., Cohen, J., Boyd, J. and Nelson, R., Relationship between plasma, RBC, and CSF lithium concentrations in human subjects, Int. Pharmacopsychiat., 14 (1979) 185-189.
56. [56] Whitworth, P., Heal, D.J. and Kendall, D.A., The effects of acute and chronic lithium treatment on pilocarpine-stimulated phosphoinositide hydrolysis in mouse brain in vivo, Br. J. Pharmacol., 101 (1990) 39-44.
57. [57] Wood, A.J. and Goodwin, G.M., A review of the biochemical and neuropharmacological actions of lithium, Psychol. Med., 17 (1987) 579-600.
58. [58] Worley, P.F., Baraban, J.M., Colvin, J.S. and Snyder, S.H., Inositol trisphosphate receptor localization in brain: variable stoichiometry with protein kinase C, Nature, 325 (1987) 159-161.
59. [59] Worley, P.F., Baraban, J.M. and Snyder, S.H., Inositol 1,4,5-trisphosphate receptor binding: autoradiographic localization in rat brain, J. Neurosci., 9 (1989) 339-346.
60. [60] Zilberman-Kaufman, M., Agam, G., Moscowits, L, Livne, A.A. and Belmaker R.H., Raised monophosphatase activity in schizophrenic patients, Clin. Chim. Acta, 209 (1992) 89-93.